E-LIB Suche - Ergebnisse für: Massarelli, Erminia

1

Spatial iTME analysis of KRAS mutant NSCLC and immunotherap..:

Zhao, Dan ; Li, Haiqing ; Mambetsariev, Isa...
npj Precision Oncology. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Updated efficacy and safety of entrectinib in NTRK fusion-p..:

Cho, Byoung Chul ; Chiu, Chao-Hua ; Massarelli, Erminia...
Lung Cancer. 188 (2024) - p. 107442 , 2024

Link: https://doi.org/10.1016/..

3

The impact of pretreatment symptom burden on long‐term qual..:

Ladbury, Colton ; Wilde, Taylor ; Amini, Arya...
Head & Neck. , 2024

Link: https://doi.org/10.1002/..

4

Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Pat..:

Neal, Joel W. ; Santoro, Armando ; Gonzalez-Cao, Maria...
JTO Clinical and Research Reports. , 2024

Link: https://doi.org/10.1016/..

5

Clinical Activity of Selpercatinib in RET-mutant Pheochromo..:

Deschler-Baier, Barbara ; Konda, Bhavana ; Massarelli, Erminia...
The Journal of Clinical Endocrinology & Metabolism. , 2024

Link: https://doi.org/10.1210/..

6

Phase II Trial of Lung Chemoembolization:

Boas, F. Edward ; Salgia, Ravi ; Waddington, Thomas...
Journal of Vascular and Interventional Radiology. 34 (2023) 12 - p. 2090-2092 , 2023

Link: https://doi.org/10.1016/..

7

Vidutolimod in Combination With Atezolizumab With and Witho..:

Negrao, Marcelo V. ; Papadimitrakopoulou, Vassiliki A. ; Price, Andrew C....
JTO Clinical and Research Reports. 4 (2023) 3 - p. 100423 , 2023

Link: https://doi.org/10.1016/..

8

Arising Novel Agents in Lung Cancer: Are Bispecifics and AD..:

Reyes, Amanda ; Pharaon, Rebecca ; Mohanty, Atish.
Cancers. 15 (2023) 12 - p. 3162 , 2023

Link: https://doi.org/10.3390/..

9

Divarasib plus cetuximab in KRAS G12C-positive colorectal c..:

Desai, Jayesh ; Alonso, Guzman ; Kim, Se Hyun...
Nature Medicine. 30 (2023) 1 - p. 271-278 , 2023

Link: https://doi.org/10.1038/..

10

A Systems Biology Approach for Addressing Cisplatin Resista..:

Ramisetty, Sravani ; Kulkarni, Prakash ; Bhattacharya, Supriyo...
Journal of Clinical Medicine. 12 (2023) 2 - p. 599 , 2023

Link: https://doi.org/10.3390/..

11

Integration of artificial intelligence in lung cancer: Rise..:

Ladbury, Colton ; Amini, Arya ; Govindarajan, Ameish...
Cell Reports Medicine. 4 (2023) 2 - p. 100933 , 2023

Link: https://doi.org/10.1016/..

12

Targeting ITGB4/SOX2-driven lung cancer stem cells using pr..:

Guo, Linlin ; Mohanty, Atish ; Singhal, Sharad...
iScience. 26 (2023) 8 - p. 107302 , 2023

Link: https://doi.org/10.1016/..

13

Prognostic Role of Biologically Active Volume of Disease in..:

Ladbury, Colton ; Abuali, Tariq ; Liu, Jason...
Clinical Lung Cancer. 24 (2023) 3 - p. 244-251 , 2023

Link: https://doi.org/10.1016/..

14

Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment fro..:

Juarez-Vignon Whaley, Juan Jose ; Afkhami, Michelle ; Onyshchenko, Mykola...
Current Treatment Options in Oncology. 24 (2023) 9 - p. 1138-1166 , 2023

Link: https://doi.org/10.1007/..

15

Predicting survival of NSCLC patients treated with immune c..:

Sayer, Michael R. ; Mambetsariev, Isa ; Lu, Kun-Han...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..